The Safety Profile of Pradaxa^®

Professor Jeffrey Weitz (McMaster University, Canada), Professor John Eikelboom (McMaster University, Canada) and Professor Christoph Diener (University of Essen, Germany) discuss the importance of balancing the benefits vs. risks of anticoagulant treatments. The multi-disciplinary experts highlight the safety and efficacy profile of Pradaxa^® from the RE-LY^® trial as well as the outcomes reported during the long-term follow up trial RELY-ABLE^® and what they mean to clinical practice.